Abstract:Activation of nicotinic acetylcholine receptors containing α4 and β2 subunits (α4/β2* nAChRs) in the mammalian brain is necessary for nicotine reinforcement and addiction. We previously identified interactions between α4/β2* nAChRs and calcium/calmodulin-dependent protein kinase II (CaMKII) in mouse and human brain tissue. Following co-expression of α4/β2 nAChR subunits with CaMKII in HEK cells, mass spectrometry identified 8 phosphorylation sites in the α4 subunit. One of these sites and an additional site we… Show more
“…For instance, estradiol has been shown to bind to the Cterminal tail of the a4 subunit to potentiate the activation of a4* nAChRs in the presence of acetylcholine, an effect that was selective for a4 as differences were not found with the a3 subunit (Curtis et al 2002). More recently, phosphorylation sites have been identified on a4b2* nAChRs, suggesting a direct role for the receptor in mediating calcium/calmodulin-dependent protein kinase II and protein kinase A intracellular signaling (Miller et al 2018). Together, these nAChR subtype specific interactions, along with cell type-specific expression patterns, may allow for selective modulation of various aspects of cholinergic signaling, thereby permitting each endogenous modulator to differentially regulate neural processes.…”
Section: Modulators Of Nachrs Influencing Expression and Functionmentioning
Nicotine underlies the reinforcing properties of tobacco cigarettes and e-cigarettes. After inhalation and absorption, nicotine binds to various nicotinic acetylcholine receptor (nAChR) subtypes localized on the pre-and post-synaptic membranes of cells, which subsequently leads to the modulation of cellular function and neurotransmitter signaling. In this chapter, we begin by briefly reviewing the current understanding of nicotine's actions on nAChRs and highlight considerations regarding nAChR subtype localization and pharmacodynamics. Thereafter, we discuss the seminal discoveries derived from genetically modified mouse models, which have greatly contributed to our understanding of nicotine's effects on the reward-related mesolimbic pathway and the aversion-related habenulo-interpeduncular pathway. Thereafter, emerging areas of research focusing on modulation of nAChR expression and/or function are considered. Taken together, these discoveries have provided a foundational understanding of various genetic, neurobiological and behavioral factors underlying the motivation to use nicotine and related dependence processes, which are thereby advancing drug discovery efforts to promote long-term abstinence.
“…For instance, estradiol has been shown to bind to the Cterminal tail of the a4 subunit to potentiate the activation of a4* nAChRs in the presence of acetylcholine, an effect that was selective for a4 as differences were not found with the a3 subunit (Curtis et al 2002). More recently, phosphorylation sites have been identified on a4b2* nAChRs, suggesting a direct role for the receptor in mediating calcium/calmodulin-dependent protein kinase II and protein kinase A intracellular signaling (Miller et al 2018). Together, these nAChR subtype specific interactions, along with cell type-specific expression patterns, may allow for selective modulation of various aspects of cholinergic signaling, thereby permitting each endogenous modulator to differentially regulate neural processes.…”
Section: Modulators Of Nachrs Influencing Expression and Functionmentioning
Nicotine underlies the reinforcing properties of tobacco cigarettes and e-cigarettes. After inhalation and absorption, nicotine binds to various nicotinic acetylcholine receptor (nAChR) subtypes localized on the pre-and post-synaptic membranes of cells, which subsequently leads to the modulation of cellular function and neurotransmitter signaling. In this chapter, we begin by briefly reviewing the current understanding of nicotine's actions on nAChRs and highlight considerations regarding nAChR subtype localization and pharmacodynamics. Thereafter, we discuss the seminal discoveries derived from genetically modified mouse models, which have greatly contributed to our understanding of nicotine's effects on the reward-related mesolimbic pathway and the aversion-related habenulo-interpeduncular pathway. Thereafter, emerging areas of research focusing on modulation of nAChR expression and/or function are considered. Taken together, these discoveries have provided a foundational understanding of various genetic, neurobiological and behavioral factors underlying the motivation to use nicotine and related dependence processes, which are thereby advancing drug discovery efforts to promote long-term abstinence.
“…Subsequent use of this approach in post-mortem cortical tissue from nicotine-dependent mice and human subjects revealed 17 dose-dependent nicotine-induced changes in protein interactions in mice, with eight of these, including CaMKIIα, recapitulated in tissue from human smokers. The molecular relevance of the proposed interaction was recently elucidated by the Picciotto group using both in vitro and in vivo preparations [43]. These studies provide an excellent example of the utility of interactome studies in identifying novel protein interactions that may serve as the basis for developing precision medicine.…”
Section: Affinity-based Proteomics: Protein Interactome As An Apprmentioning
Drug addiction is a complex disorder driven by dysregulation in molecular signaling across several different brain regions. Limited therapeutic options currently exist for treating drug addiction and related psychiatric disorders in clinical populations, largely due to our incomplete understanding of the molecular pathways that influence addiction pathology. Recent work provides strong evidence that addiction-related behaviors emerge from the convergence of many subtle changes in molecular signaling networks that include neuropeptides (neuropeptidome), protein-protein interactions (interactome) and post-translational modifications such as protein phosphorylation (phosphoproteome). Advancements in mass spectrometry methodology are well positioned to identify these novel molecular underpinnings of addiction and further translate these findings into druggable targets for therapeutic development. In this review, we provide a general perspective of the utility of novel mass spectrometry-based approaches for addressing critical questions in addiction neuroscience, highlighting recent innovative studies that exemplify how functional assessments of the neuroproteome can provide insight into the mechanisms of drug addiction.
“…Just as protein phosphorylation plays a key role in the molecular mechanisms underlying drug addiction, the articles by Bertholomey et al [31] and Miller et al [32] indicate that this PTM also plays an important role in alcohol use disorders (AUDS) and nicotine addiction, respectively. Bertholomey et al [31] describe how early life stress is associated with an increased risk of developing AUDs.…”
mentioning
confidence: 99%
“…As described by Miller et al [32], high-affinity nicotinic acetylcholine receptors containing α4 and β2 subunits (α4/β2* nAChRs, where * denotes other, potentially unidentified subunits) are essential for the rewarding and reinforcing properties of nicotine. α4/β2* nAChRs are ion channel-containing proteins that flux positive ions, including calcium, in response to nicotine or the endogenous neurotransmitter acetylcholine.…”
mentioning
confidence: 99%
“…Interactions have previously been identified between α4/β2* nAChRs and calcium/calmodulin-dependent protein kinase II (CaMKII) in mouse and human brains [33,34]. Following co-expression of α4/β2 nAChR subunits with CaMKII in human embryonic kidney (HEK) cells, MS/proteomic analyses described by Miller et al [32] identified eight phosphorylation sites in the α4 subunit. One of these sites and an additional site were identified when α4/β2* nAChRs were dephosphorylated and then incubated with CaMKII in vitro, while three phosphorylation sites were identified following incubation with protein kinase A (PKA) in vitro.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.